| Authors: |
Dalli J; William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Center for Inflammation and Therapeutic Innovation, Queen Mary University of London, London, UK., Kitch D; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, USA., O'Brien MP; Regeneron Pharmaceuticals Inc., Tarrytown, USA., Hunt PW; Department of Medicine, University of California, San Francisco School of Medicine, USA and Department of Veterans Affairs Medical Center, San Francisco, USA., Funderburg N; Division of Medical Laboratory Science, School of Health and Rehabilitation Sciences, Ohio State University, Columbus, USA., Moisi D; Department of Medicine, School of Medicine, Case Western Reserve University, Cleveland, USA., Gupta A; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, USA., Brown TT; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, USA., Tien PC; Department of Medicine, University of California, San Francisco School of Medicine, USA and Department of Veterans Affairs Medical Center, San Francisco, USA., Aberg JA; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, USA., Shivakoti R; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA. Electronic address: rs3895@cumc.columbia.edu. |
